FindTrial
Sign In

Microcirculatory dysfunction plays a key role in uremic vasculopathy

Microcirculatory dysfunction plays a key role in uremic vasculopathy - ADMIRED = A'Dam Microcirculatory Insufficiency in REnal Disease

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON30604
Enrollment
120
Registered
2007-06-08
Start date
2007-04-01
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

kidney disease renal failure

Interventions

None listed

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients > 18 years with chronic renal failure stages I-V.

Exclusion criteria

Exclusion criteria: Patients

Design outcomes

Primary

MeasureTime frame
The microcirculation is disturbed in renal patients proportionally to the degree of renal failure. Pathophysiological insight into this phenomenon might show the way towards new treatment strategies.—

Secondary

MeasureTime frame
Secondary markers of endothelial dysfunction (vWF, ICAM, etc), inflammation (CRP, cytokines) and insulin resistence (HOMA-IR) will be correlated with the primary study parameters.—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)